* Enfusion Inc ENFN.N ENFN.K is expected to report
results on
August 9.
* The Chicago Illinois-based company is expected to report
revenue of $35.58 million, according to the mean estimate from 6
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Enfusion Inc is for
earnings of 2 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Enfusion
Inc is
$12.5, below its last closing price of $13.36.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2022 0.03 0.03 0.07 Beat 124.8
Dec. 31 2022 0.03 0.04 0.02 Missed -43.6
Sep. 30 2021 0.04 0.04 0.03 Missed -18.9
This summary was machine generated August 6 at 02:09 GMT. All
figures in US dollars unless otherwise stated